Tag: Prescription Drugs
Orexin Receptor 2 Agonist Improves Sleepiness in Narcolepsy
Improvement seen in measures of sleepiness, cataplexy over eight weeks versus placebo, but drug was associated with hepatotoxic effects
2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis
Oral disease-modifying therapies dominated new initiations by 2020 to 62.3 percent
Voclosporin Safe, Effective for Long-Term Treatment of Lupus Nephritis
Benefits include maintenance of urine protein creatinine ratio reductions, preserved kidney function
Maternal Labor Epidural Analgesia May Be Linked to Autism in Children
Risk increased with labor epidural analgesia alone and labor epidural analgesia and oxytocin compared with no exposure
Younger Kidney Cancer Patients on VEGF Inhibitors at Elevated Risk for Hypertension
Vascular endothelial growth factor inhibitors tied to hypertension among people aged 18 to 39 years being treated for renal cancer
Major Drug Shortages Not Likely After Tornado Damages Pfizer Plant, FDA Says
Pfizer is working to repair the damage and mitigate any shortage of drugs made at the facility
SGLT2i Use Linked to Reduced Risk for Flare in Adults With Gout, T2D
Flare rate lower among SGLT2i initiators than DDP-4i initiators; gout-primary emergency department visits, hospitalizations also reduced
Ketamine Efficacious for Treatment-Resistant Depression
Four-week course efficacious and safe for treatment-resistant depression
Fruquintinib Provides Meaningful Benefit in Refractory Metastatic CRC
Significantly improved overall survival seen with fruiquintinib versus placebo, with favorable safety profile
JAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia
Study shows safety and tolerability of JAK inhibitors acceptable
